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Abstract. We report the identification of fibronectin 
receptors on thymocytes and T  lymphoma cells. 
Affinity chromatography of extracts of the T  cell lym- 
phoma, WR16.1,  on a  fibronectin-Sepharose column 
combined with specific elution using a  synthetic pep- 
tide containing the cell attachment-promoting se- 
quence, arginine-glycine-aspartic acid, yielded two 
polypeptide components having apparent molecular 
masses of ~,160 kD reduced and  175 and  150 kD non- 
reduced. Immunoprecipitations from surface-iodinated 
WR16.1  cells or fibronectin-adherent thymocytes using 
a  rabbit antiserum raised against the fibronectin recep- 
tor that is present on human fibroblasts revealed, in 
each case, the same two radiolabeled components. In 
contrast, immunoprecipitation from fibronectin- 
nonadherent T  lymphoma cells, designated WR2.3,  re- 
vealed the presence of only the smaller subunit.  A1- 
though the lymphocyte receptor and the fibronectin 
receptor identified on fibroblasts share immunologic 
determinants, they differ in that the molecular mass of 
the lymphocyte protein is larger.  Moreover, trypsiniza- 
tion of either thymocytes or the WR16.1  T  lymphoma 
cells resulted in a  subsequent loss of their ability to 
adhere to fibronectin-coated substrates and a  reduction 
in the electrophoretic mobility of each of the polypep- 
tide chains of the fibronectin receptor present on their 
surfaces. These changes, however, were not observed 
with normal rat kidney fibroblasts or mouse 3T3 
fibroblasts in response to trypsinization. The data es- 
tablish the existence on normal lymphocytes of 
fibronectin receptors that are quite similar to those 
found on fibroblasts. The possible function of this 
molecule on thymocytes is discussed. 
F 
IBROr~ECTIN has emerged as the prototype of extracel- 
lular matrix molecules that promote the adhesion of 
cells  (Klebe,  1974; Pearlstein,  1976; Rubin  et al., 
1979; Ruoslahti and Hayman, 1979; Grinnell, 1980). The pri- 
mary site within the fibronectin molecule that is recognized 
by cells consists of the tripeptide sequence, L-arginyl-glycyl- 
L-aspartic  acid  (RGD) 1  (Pierschbacher  and  Ruoslahti, 
1984a) for which there exists at least one cell surface recep- 
tor (Hasegawa et al.,  1985; Horwitz et al.,  1985; Pytela et 
al.,  1985a). 
We have previously identified a subset of thymocytes that 
bind to fibronectin but not to other extracellular matrix pro- 
teins such as laminin, collagen, or vitronectin (Cardarelli 
and  Pierschbacher,  1986). The  interaction  between  this 
group of thymocytes and the fibronectin molecule appears to 
be mediated by the same RGD sequence (Pierschbacher and 
Ruoslahti,  1984a;  Hynes,  1987) recognized by the  fibro- 
nectin receptor on fibroblastic cells (Pytela et al., 1985a), in- 
dicating that the receptor on thymocytes is the same as that 
on fibroblasts or is a member of the same family of RGD- 
directed receptors (Ruoslahti and Pierschbacher, 1986). The 
presence of fibronectin receptors on other hemopoietic cells 
has  also been reported (Giancotti et al.,  1986; Patel and 
1.  Abbreviations used in  this paper:  GRGDSP, glycine-arginine-glycine- 
aspartic  acid-serine-proline; GRGESP,  glycine-arginine-glycine-glutamic 
acid-serine-proline; RGD,  L-arginyl-glycyl-L-aspartic  acid. 
Lodish, 1986; Savagner et al.,  1986). The possibility that 
distinct fibronectin receptors  might exist, though, is  sug- 
gested by the findings that platelets have a distinct fibronectin 
receptor that recognizes also other proteins containing the 
RGD  sequence  (Pytela et al.,  1986),  and that monocytes 
(Bevilacqua et al., 1981; Hosein and Bianco, 1985) and mac- 
rophages (Rourke et al.,  1984) have fibronectin receptors 
that are functionally sensitive to trypsin whereas the fibro- 
blast fibronectin receptor is resistant to trypsin in the pres- 
ence of calcium (Oppenheimer-Marks and GrinneU, 1984). 
Furthermore, the monocyte receptor (Hosein and Bianco, 
1985) appears to be immunologicaUy distinguishable from 
the fibroblast receptor even though it, too, seems to recog- 
nize the RGD sequence in fibronectin (Wright and Meyer, 
1985). To obtain more direct information on the similarities 
or differences of lymphocyte fibronectin receptors with re- 
ceptors serving a similar function on other types of cells, we 
have isolated the RGD-directed fibronectin receptor from T 
lymphocytes. 
Materials and Methods 
Preparation of  CeUs 
Murine thymocy~s were isolated as described previously (Cardarelli and 
Pierschbacher, 1986). The fibronectin-adherent thymocyte population was 
obtained by selective attachment to fibronectin-coated  substrates (10 Bg/ml). 
The adherent lymphocytic cells were collected by treating them for l0 min 
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media (DME) as described (Hayman et al., 1985). Contaminating noniym- 
phoid cells such as thymic macrophages and dendritic cells required an in- 
cubation period of 1 h for detachment and thus were not present in thymo- 
cytes prepared by this procedure.  This was verified by replating the cells 
on fibronectin-coated  substrates and visually inspecting the reattached cells. 
Lymphoma cells WR16.1, WR2.3  (Raschke,  1980),  and EL-4  (Gorer, 
1950), normal rat kidney fibroblasts, or mouse 313 fibroblasts were cultured 
in DME supplemented  with 10% heat-inactivated  fetal calf serum, gluta- 
mine (2 mM), penicillin (100 U/ml), and streptomycin  (100 Ilg/mi) (Irvine 
Scientific,  Santa Ana, CA). 
Affinity Chromatography 
The 120-kD chymotryptic cell-binding  fragment  of fibronectin  was prepared 
and coupled to cyanogen bromide-activated Sepharose  (Sigma  Chemical 
Co., St.  Louis,  MO) as described previously  (Pierschbacher et al.,  1981; 
Pytela  et al.,  1985a). The cells were surface labeled with 1 mCi of 125I- 
sodium  iodide and 0.2 mg/mi of lactoperoxidase.  1  x  109 WR16.1 cells 
(5.0 ml of packed cells) were solubilized in 100 mM octylglucoside  contain- 
ing 3 mM phenylmethylsulfonyl  fluoride in PBS (extraction buffer) accord- 
ing to methods described by Pytela et al. (1985a). The extract was applied 
to a 3-ml column of 120-kD fragment-Sepharose  and nonbound material 
was removed by washing with 30 ml of extraction buffer. Elution of bound 
material was accomplished, after washing with 6 ml of a 1 mg/ml solution 
of glycine  arginine-glycine-ghitamic  acid-serine-pmline (GRGESP)  pep- 
tide, by elutmg with 6 ml of 1 mg/ml glycine-arginine-glycine-aspartic  acid- 
serine-proline (GRGDSP)  peptide in extraction buffer. 
Liposome-binding Assay 
[3H]phosphatidylcholine  liposomes containing l~I-labeled purified  fibro- 
nectin receptor were prepared by the method of Mimms et al., (1981) as de- 
scribed (Pytela et al., 1985a and b, 1987). The diluted liposomes were then 
added to microtiter wells which had been coated with 20 gg/ml fibronectin, 
vitronectin (Hayman et al., 1983), or BSA and incubated overnight at 40C. 
Unbound material was removed,  the bound liposomes were solubilized  in 
1% SDS, and the radioactivity  was determined. To purify the liposomes, 
they were suspended in 30%  sucrose and centrifuged at 15°C for 5 h at 
100,000 rpm. The liposomes  were recovered at the top of the sucrose gra- 
dient and quantitated by both gamma and scintillation counting before anal- 
ysis by SDS-PAGE. 
Immunoprecipitation of  Receptors 
Cells (5-10  ×  107) were surface labeled with 1 mCi 125I-sodium  iodide and 
0.2 mg/ml of lactoperoxidase.  A cell extract was made by adding 400 gl of 
extraction buffer (see above),  incubated for 20 min, and centrifuged, and 
the supernatant was collected.  '~800 gl of immunoprecipitation  buffer (0.1% 
SDS, 0.5% Triton X-100, 0.5% deoxycholic acid [sodium salt] in PBS) was 
then added to the supernatant.  The extract was incubated at 4"C for 20 rain 
and centrifuged at 12,500 g for an additional 20 rain. The supernatant was 
collected and 50 gl of the respective antibodies (30 gg/ml) was added. This 
was  incubated overnight  at 4°C.  Protein A-Sepharose  was  added to the 
extract-antibody  suspension and incubated for 1 h at 24°C then washed three 
times with immunoprecipitation  buffer containing  0.5 M NaCI, followed by 
one wash with RIPA alone and one wash with PETS. This was subsequently 
solubilized by boiling (100*C) in IX sample buffer (3 % SDS, 5 % 2-mercap- 
toethanol, 10% glycerol,  200 mM Tris-HCl, pH 6.8, and 0.001% Brom- 
phenol Blue) and analyzed by SDS-PAGE (Laemmli,  1970). 
Trypsinization of  Fibronectin Receptors 
Mouse 3T3 fibroblasts or normal rat kidney fibroblasts were detached from 
the culture dishes with 100 gg/ml trypsin (Sigma Chemical Co.) and washed 
twice  in  PBS  containing  1  mg/ml  BSA.  Thymocytes,  lymphoma cells 
(WRI6.1), mouse 3T3 fibroblasts, and normal rat kidney fibroblasts (NRK) 
were collected  and  100 gg/ml trypsin (Sigma  Chemical Co.) containing 
1,300 U/ml in DME was added. This was incubated for 30 min at 37°C fol- 
lowed by three washes in PBS containing 500 Ixg/ml soy bean trypsin inhibi- 
tor (Sigma Chemical Co.).  Both trypsinized and nontrypsinized cells were 
assessed for the presence of fibronectin receptor on their surface by immu- 
noprecipitation and for their ability to bind to microwells  which had been 
coated overnight with fibronectin (10 I.tg/ml in 100 Ixl per well). This yields 
wells coated at an approximate  density of fibronectin of 0.3 gg/cm  2 (Eng- 
vail and Perlmann, 1972; Solonen and Vaheri,  1979). Attachment of tryp- 
Figure 1. Immunoprecipitation of fibronectin receptors on T  lymphoma cells and thymocytes. Thymic lymphoma cells (lanes 1 and 2) and 
fibronectin-adherent thymocytes (lanes 3 and 4) were surface labeled with t25I and immunoprecipitated with rabbit anti-human fibroblast 
fibronectin receptor antibody (lanes 2 and 4) or preimmune IgG (lanes I  and 3) under (A) nonreducing conditions or (B) reducing condi- 
tions. (C) Fibronectin-adherent (lanes I  and 2) and fibronectin-nonadherent  thymocytes (lanes 3 and 4), isolated by panning on fibronectin- 
coated substrates, labeled with ~25I and immunoprecipitated with rabbit anti-human fibroblast fibronectin receptor antibody (lanes 2  and 
4), or preimmune IgG (lanes I  and 3) under reducing conditions. Lane 5 depicts molecular mass standards, myosin (200 kD), phosphory- 
lase B  (94 kD),  BSA (67 kD),  and ovalbumin (43 kD).  K,  thousands. 
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or presence of 500 I.tg/ml soy bean trypsin inhibitor, was determined after 
a 2-h incubation at 24°C as described (Cardarelli and Pierschbacher, 1986). 
SDS-PAGE and Au toradiography 
A 7.5 % SDS-PAGE analysis of eluted material was carried out under reduc- 
ing and nonreducing conditions (Laemmli, 1970). Autoradiography was per- 
formed by placing Kodak XAR X-ray film between the dried gel and a Cro- 
nex Lightning Plus intensifying screen (DuPont Instruments, Newtown, 
CT)  at  -70°C  for  3-5  d.  t4C-labeled standards used were  myosin (200 
kD), phosphorylase B (94 kD), BSA (67 kD), and ovalbumin (43 kD) (New 
England Nuclear, Boston, MA). For scanning the X-my, an automatic com- 
puting densitometer ACD-18 (Gelman Sciences, Inc., Ann Arbor, MI) was 
used and read at 450 nm. 
Results 
Immunologic Relationship between 
the Fibronectin Receptors on T Lymphocytes and 
Those on Fibroblastic Cells 
To begin to address the question of whether T lymphocytes 
can express a fibronectin receptor similar to that found on 
fibroblastic  cells,  a  rabbit  antiserum  raised  against  the 
fibronectin  receptor  isolated  from human  placental  tissue 
was used to immunoprecipitate labeled material from fibro- 
nectin-adherent murine thymic lymphoma cells (designated 
WR16.1)  or  from  fibronectin-adherent  mouse  thymocytes 
each of which  had been surface iodinated.  In both cases, 
SDS-PAGE of the precipitate under nonreducing conditions 
revealed two radiolabeled components having approximate 
apparent molecular masses of 175  and  150 kD (Fig.  1 A). 
When reduced, these two bands migrated as a closely spaced 
doublet with a Mr of 'M60 kD (Fig.  1 B).  When immuno- 
precipitates from equal numbers of surface-iodinated, fibro- 
nectin-adherent  and  -nonadherent  thymocytes  were  com- 
pared, smaller amounts of labeled receptor could be obtained 
from the preparation of nonadherent cells (Fig.  1 C), which 
was visible only after prolonged exposure. 
To determine  whether  the  structures  recognized on the 
thymocyte by this antibody included a functional fibronectin 
receptor, we asked whether the antibody would inhibit the 
attachment of thymocytes to fibronectin. Indeed, when anti- 
body to the human fibronectin receptor was included in an 
assay  designed  to  detect  the  adhesion  of  thymocytes  to 
fibronectin, it reduced the number of adherent cells to back- 
ground levels (Fig. 2). This inhibition was dependent upon 
the concentration of antibody present. In contrast, no inhibi- 
tion was observed when an antibody to the vitronectin recep- 
tor, a similar cell surface adhesion molecule, was included 
in the assay at concentrations capable of inhibiting attach- 
ment of vitronectin-adherent cells. 
Isolation of  Functional Fibronectin Receptor  from a 
Murine T Cell Lymphoma 
By using affinity chromatography of cell extracts over a ma- 
trix of insolubilized fibronectin, a cell surface receptor can 
be isolated from osteosarcoma cells (Pytela et al., 1985a) or 
from tissue (Pytela et al.,  1986).  To determine whether the 
lymphocyte protein recognized by the anti-human fibronec- 
tin receptor antibody might itself be a functional fibronectin 
receptor, we applied the affinity chromatography procedure 
to  fibronectin-adherent  lymphocytic  cells.  Because  it  is 
1.0 
0.8 
0.6- 
o  g 
< 
0.4- / 
0.2 
;  I  I  /  2  4 
Specific  Antibody ug/ml 
Figure 2.  Inhibition  of thymocyte  attachment  to  fibronectin  by 
antifibroblast fibronectin receptor antibody. Thymocytes (2  x  107 
cells/ml) were preincubated in the (open triangle) absence or pres- 
ence  of (solid  circles)  protein  A-purified  anti-human fibroblast 
fibronectin  receptor  antibody  or  (open circles) anti-human 
vitronectin receptor antibody at the designated concentrations  for 
30 min at 24°C.  Attachment of thymocytes to fibronectin was as- 
sessed  as  described  in  Materials  and  Methods.  Each  point 
represents the mean +  SEM (n  =  6). 
difficult  to  obtain  large  numbers  of  fibronectin-adherent 
mouse thymocytes and because we had found the fibronectin 
receptor on WR16.1 cells to share the unique characteristics 
of the thymocyte receptor, we examined detergent extracts of 
the WR16.1 cells that had been surface iodinated for func- 
tional  receptor.  The  material  eluted  from the  fibronectin 
matrix  with  an  Arg-Gly-Asp-containing  synthetic  peptide 
migrated on  SDS-PAGE under  nonreducing  conditions  as 
two components with apparent molecular masses of 175 and 
150 kD (Fig.  3 A).  Reduced,  a closely spaced polypeptide 
doublet  having  molecular weights  near  160  kD  could  be 
visualized (Fig.  3 B).  Immunoprecipitation of the material 
specifically eluted  from the  fibronectin-Sepharose column 
with  the  anti-fibroblast  fibronectin  receptor  antibody  re- 
vealed  two  components  with  a  similar  molecular  mass. 
When  the  same  affinity  chromatography  experiment  was 
done using  cells that had been metabolically labeled with 
[35S]methionine,  the  same  two  polypeptide  chains  were 
eluted from the column (not shown). No material was eluted 
with a control peptide containing the sequence Arg-Gly-Glu 
that  does  not  have  cell  attachment-promoting  activity 
(Pierschbacher and Ruoslahti, 1984b).  A 70-kD protein con- 
tinued to leach out of the column even after extensive wash- 
ing. The amount of this protein diminished during the elution 
period and was not affected by the presence of peptide in the 
elution buffer. Also, the amount of this protein was not con- 
sistent from experiment to experiment (see Fig. 3), indicat- 
ing that its interaction with the affinity matrix is nonspecific. 
Moreover, the 70-kD protein did not become incorporated 
into liposomes (see below), indicating that it is not necessary 
for the receptor to interact with fibronectin. 
Cardarelli and Pierschbacher Lyn~ohocyte Adhesion Receptor  501 Figure 3. SDS-PAGE of fractions eluted from fibronectin-Sepharose column.  '25I-labeled  T lymphoma cells were solubilized and applied 
to a fibronectin-Sepharose column as described  in Materials and Methods. Fractions of 0.5 ml were collected and 75 ~tl of each fraction 
was applied per lane and analyzed under  (A) nonreducing conditions or (B) reducing conditions.  The bound material was eluted from 
the column by adding 6 ml of 1 mg/ml GRGESP followed by 6 ml of 1 mg/ml GRGDSP. The samples analyzed under nonreducing and 
reducing conditions came from different experiments. Molecular mass markers which are shown are myosin (200 kD), phosphorylase B 
(94 kD), BSA (67 kD), and ovalbumin (43 kD).  K, thousands. 
Specificity of  Binding of  Fibronectin Receptor 
Containing Liposomes to ~bronectin 
We next wanted to determine if the proteins eluted from the 
fibronectin-Sepharose  column  could  be  integrated  into  a 
liposome model membrane and  retain  their  specificity of 
binding to fibronectin as the fibroblast receptor does (Pytela 
et al.,  1985a).  Liposomes containing  the  165/155-kD  pro- 
0.25 
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Figure 4.  Gel scan of SDS-PAGE fractions obtained after sucrose 
gradient fractionation of LS0/|75-kD protein containing  liposomes. 
Liposomes containing the 1501175-kD proteins were fractionated by 
sucrose  gradient  centrifugation  as  described  in  Materials  and 
Methods. The top 200-~tl fraction of the gradient was analyzed by 
SDS-PAGE under  nonreducing  conditions  (solid line) and com- 
pared with material containing the 150/175-kD protein before incor- 
poration into liposomes (dashed  line). The density of the gel bands 
was determined by using an automatic computing densitometer and 
read at an absorbance  of 450 nm. 
teins,  purified by  sucrose  gradient  centrifugation,  showed 
that the receptor incorporated into liposomes was identical 
to the receptor which was purified by affinity chromatogra- 
phy (Fig. 4). Moreover, liposomes carrying these two poly- 
peptides did attach to fibronectin-coated substrates but not to 
vitronectin  or  BSA  coated  surfaces.  That  the  binding  to 
fibronectin was specific, was further demonstrated by the fact 
that addition of 1 mg/ml of the Arg-Gly-Asp-containing pep- 
tide completely reduced the binding to background levels. In 
contrast,  the  control  peptide  did  not  inhibit  the  liposome 
binding  to  fibronectin  (Fig.  5).  The  percentage  of added 
counts which bound to fibronectin was found to be ~2%. 
This, however, does not represent all of the liposomes that 
have incorporated receptor, and is more probably a reflection 
of the  capacity of the  substrate because,  when nonbound 
receptor liposomes were placed in a second microtiter well 
that had been coated with fibronectin, an additional 2 % of 
the counts bound to the substrate in a  specifc manner. 
Differences between the Lymphocyte lqbronectin 
Receptor and the Fibroblast Fibronectin Receptor 
Immunoprecipitation of the material affinity purifed  from 
mouse T  lymphoma cells with the antibody against the hu- 
man fibroblast fibronectin receptor confirmed that the mouse 
protein was related to the human receptor, and we conclude 
that it serves as a receptor for fibronectin on the T lympho- 
cyte.  However, like the material immunoprecipitated from 
thymocytes, the  protein affinity purified  from the  WR16.1 
cells  appeared  slightly  larger  when  compared  with  the 
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Figure 5. Binding of liposomes containing the 150/175-kD protein 
to  fibronectin  (FN)-,  vitronectin  (VN)-coated  substrates.  Lipo- 
somes were prepared as outlined in Materials and Methods. Dishes 
were coated with 20 Ixg/ml of the indicated proteins.  Attachment 
(counts per minute bound) of 3H-labeled liposomes containing the 
150/175-kD protein was assessed after an overnight incubation at 
4°C. Where indicated, synthetic peptides (RGD, Gly-Arg-Gly-Asp- 
Ser-Pro; RGE, Gly-Arg-Gly-Glu-Ser-Pro) were added to the wells 
with the liposome  suspension.  The results from one experiment 
representative  of six are shown with the mean of three  replicate 
wells expressed  +SD. 
fibronectin receptor described on human osteogenic sarcoma 
cells (Pytela et al., 1985a) or compared with the receptor im- 
munoprecipitated from normal rat kidney cells or murine 
3T3 cells both of which are 140 kD reduced; 160 and 125 kD 
nonreduced (for simplicity we will refer to the smaller recep- 
tor  as  a  "fibroblast fibronectin  receptor").  The molecular 
mass differences of the fibronectin receptors on fibroblasts 
and lymphocytes does not appear to be due to variations in 
N-linked carbohydrates because the removal of N-linked car- 
bohydrates by enzymatic treatment of either normal rat kid- 
ney cells, mouse 3T3 cells, or T  lymphoma (WR16.1) cells 
with  N-glycanase  (Chu,  1986;  Plummer  et  al.,  1984), 
resulted in similar changes in electrophoretic mobilities of 
the fibronectin receptor from all cells tested. 
To further characterize the fibronectin receptor on thymo- 
cytes,  we asked whether  the  ability of thymocytes or the 
WR16.1  cells  to  attach  to  fibronectin  substrates  could  be 
affected by pretreatment of the  ceils with  trypsin.  Fig.  6 
demonstrates that both mouse thymocytes and the T  lym- 
phoma cells lose their capacity to recognize fibronectin after 
trypsinization  even  when  the  adhesion  assays are carried 
out in the presence of 500 Ixg/ml soybean trypsin inhibitor, 
whereas normal rat kidney cells or mouse 3T3 cells do not. 
These data suggested that differences may exist between the 
thymocyte fibronectin receptor and the fibronectin receptor 
on other types of cells. Immunoprecipitation of fibronectin 
receptor from trypsinized and nontrypsinized WR16.1 cells 
showed that the major effect of trypsin was on the high mo- 
lecular mass component,  changing its apparent molecular 
mass from  175  to  '~163 kD  (Fig.  7).  However, the  lower 
subunit  also appeared slightly  smaller after trypsinization 
(Fig. 7). SDS-PAGE of fibronectin receptor immunoprecipi- 
tated from NRK cells or 3T3 cells revealed two bands having 
apparent molecular masses of 160 and 125 kD. In agreement 
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Figure 6.  Effect of trypsin treatment  on the adhesion of ceils to 
fibronectin-coated substrates. Cells were preincubated in the pres- 
ence or absence of 100 Ixg/ml  trypsin for 30 min at 37°C. After three 
washes with  500  ~tg/ml soybean trypsin inhibitor,  T  lymphoma 
cells (WR16.1) (5  x  1@ cells per well), thymocytes (2  x  106 cells 
per well), normal rat kidney fibroblast cells (NRK) (5  x  104 cells 
per well), or mouse 3T3 fibroblast ceils (5  ×  104 cells per well) 
were allowed to attach to microweUs which had been coated with 
fibronectin (10 ~tg/ml). The maximal attachment of each cell type 
to fibronectin  in the  absence  of trypsinization  was expressed  as 
100% and represents 80--90% of the ceils plated in each case with 
the exception of thymocytes where only 10% are fibronectin adher- 
ent (Cardarelli and Pierschbacher,  1986) and the adhesion of tryp- 
sinized cells are expressed relative to those values. Mean 5: SEM, 
are expressed (n  =  8). 
with the functional resistance of the fibroblast receptor to 
trypsin, its electrophoretic mobility was also unaffected by 
pretreatment of the cells with trypsin (Fig.  7 A). 
Fibronectin Receptor Epitopes on a 
Fibronectin-nonadherent T Lymphoma Cell 
Table I demonstrates that whereas thymocytes, WR16.1 cells, 
and EL-4 cells bind to fibronectin, another T lymphoma cell 
line designated WR2.3 does not. Consistent with this func- 
tional  lack  of  adhesion,  immunoprecipitation  with  the 
anti-human fibroblast fibronectin receptor antibody revealed 
the presence of only the 13 subunit on WR2.3 cells (Fig. 8), 
suggesting that the ¢t subunit of the receptor is required for 
function of the receptor. 
Table L Attachment of Thymocytes or T Cell Lines 
to Fibronectin* 
Cells  Absorbance* 600 nm 
Thymocytes  0.977 +  0.074 
WR16.1  1.588 +  0.090 
WR2.3  0.061 +  0.011 
EL-4  1.496 + 0.087 
* Absorbance (600 nm) of adherent cells stained with toluidine blue was meas- 
ured using a Titertek ELISA plate reader. Mean -t- SEM are expressed (n =  6). 
$ Wells were coated with fibronectin at a concentration of 10 Ixg/ml. Fibronec- 
tin was prepared in our laboratory from human plasma. The minimal absor- 
bance due to trapping of cells in BSA-coat~l wells has been subtracted. 
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of  fibronectin  receptors  on 
trypsinized cells. (A) Normal 
rat kidney ceils were treated 
with trypsin (lanes 3 and 4) or 
buffer without trypsin (lanes 1 
and 2), radiolabeled with 125I, 
and immunoprecipitated with 
rabbit  anti-human  fibroblast 
fibronectin receptor antibody 
(lanes 2 and 3) or preimmune 
IgG  (lanes  I  and  4)  under 
nonreducing  conditions.  (B, 
C)  T  lymphoma  cells  were 
treated with trypsin  (lanes 1 
and 3) or buffer without tryp- 
sin (lane 2) and immuno-pre- 
cipitated  with rabbit  anti- 
human  fibroblast  fibronectin 
receptor antibody (lanes 2 and 
3)  or preimmune  IgG  (lane 
1). Lane 5 represents molec- 
ular  mass markers,  myosin 
(200  kD),  phosphorylase  B 
(94 kD),  BSA (67 kD),  and 
ovalbumin (43 kD). K, thou- 
sands. 
Discussion 
We  have  identified  a  glycoprotein  on  the  surface  of 
fibronectin-adherent  murine  thymocytes  (Cardarelli  and 
Pierschbacher, 1986) as well as on mouse T lymphoma cells 
that  is  immunologically  and  functionally  related  to  the 
fibronectin receptor isolated  from human  osteogenic sar- 
coma cells or normal human placental tissue (Pytela et al., 
1985a;  Pytela et  al.,  1987).  The lymphocyte molecule is 
similar to the fibroblast fibronectin receptor in that it binds 
from detergent extracts of the cells to a matrix of insoluble 
fibronectin and can be eluted from that affinity matrix with 
soluble synthetic peptides containing the cell attachment de- 
terminant  of fibronectin  (RGD).  However,  this  molecule 
differs from the fibroblast receptor, in its apparent size and 
its sensitivity to proteolysis by trypsin. Despite these differ- 
ences, based on its presence on fibronectin-adherent thymo- 
cytes on its behavior on SDS-PAGE, which is characteristic 
of the known RGD-directed receptors (Pytela et al.,  1986), 
and on its ability to confer a fibronectin-binding capacity to 
phosphatidylcholine liposomes, we conclude that this lym- 
phocyte protein serves as a receptor for fibronectin on these 
cells. 
The physiological function of the fibronectin receptor on 
thymocytes and  T  lymphoma cells is  currently unknown. 
Most of the events involved in thymocyte differentiation ap- 
pear to  take place  in  the thymus  (Rothenberg and  Lugo, 
1985;  Stutman,  1978; Metcalf,  1966).  Because of this,  we 
have speculated that the presence of fibronectin receptors on 
thymic lymphocytes may be important for their differentia- 
tion. It has been suggested that attachment of myeloid cells 
to fibronectin-coated surfaces triggers the cell to phagocytize 
C3b- and C3bi-coated particles (Wright et al.,  1983;  Pom- 
mier et al., 1983). Complement receptor activation is a rapid 
and reversible process that can be regulated by the RGD- 
binding site of fibronectin (Wright and Meyer,  1985).  Ac- 
cordingly, fibronectin receptors may play an important role 
in the differentiation of monocytes into a more active phago- 
cytic cell. Conversely, homotypic lymphocyte aggregation is 
stimulated by phorbol esters,  and this aggregation can be 
blocked by monoclonal antibodies to lymphocyte function- 
associated antigen-1  (LFA-1) (Rothlein and Springer,  1986). 
It is therefore conceivable that like the complement receptor 
or  lymphocyte function-associated antigen-1  (Springer  et 
al., 1982), fibronectin receptor activity on lymphocytes may 
be coupled to cell activation either as an initiator of activa- 
tion or as a  response to activating signals.  Perhaps,  as in 
other systems (Gospodarowicz et al., 1978), the extracellular 
matrix may provide the developing T  lymphocyte with  a 
competence-inducing signal that would allow it to respond 
to  growth-  and  differentiation-inducing factors within  the 
thymus. Alternatively, Savagner et al., 1986, found that chick 
pre-T lymphocytes could be induced by a factor from the thy- 
mus to penetrate a basement membrane in vitro. Thus, it is 
possible that chemotactic factors, antigen activation, or hor- 
mone type stimuli could induce the expression of fibronectin 
receptors on circulating lymphocytes, enabling them to tra- 
verse connective tissue and enter lymphoid organs or sites 
of inflammation. Indeed, deposits of fibronectin have been 
found in lymph nodes (DArdenne et al., 1983) and in buccal 
mucosa  associated  with  T  lymphocytes (Matthews  et al., 
1986), and it has been proposed that the connective tissue of 
the thymic interlobular septae could be the major pathway for 
the traffic of lymphocytes both into and out of the thymus 
(Kendall,  1981). We and others (Berrih et al.,  1985)  have 
found by immunofluorescence abundant fibronectin in this 
region. 
It has also been postulated that the interaction of erythroid 
and myeloid progenitor cells with fibronectin may represent 
a mechanism whereby these cells are anchored in the bone 
marrow until they receive the proper signals for differentia- 
The Journal of Cell Biology, Volume 105, 1987  504 Figure 8. Identification of the I~ subunit of the fibronectin receptor 
on a fibronectin-nonadherent T lymphoma cell. Thymic lymphoma 
cells, WR2.3, were surface labeled with 125I and immunoprecipi- 
tated with rabbit anti-human  fibroblast fibronectin receptor anti- 
body (lane 3) or preimmune IgG (lane 2) under nonreducing condi- 
tions. Lane 1 depicts molecular mass standards, myosin (200 kD), 
phosphorylase B (94 kD), BSA (67 kD), and ovalbumin (43 kD). 
tion and migration (Giancotti et al., 1986; Patel and Lodish, 
1986).  Indeed, reticulocytes or uninduced murine erythro- 
leukemia cells attach to fibronectin and this adhesion is lost 
upon differentiation (Patel and Lodish,  1984;  Patel et al., 
1985). Perhaps the fibronectin receptor serves to hold the de- 
veloping thymocyte within the thymus until it has matured 
and is ready to emigrate to the periphery. The distinction be- 
tween these and other possible functions of the fibronectin 
receptor on T  lymphocytes awaits  further study. 
We have shown here that there are differences in sizes be- 
tween the fibronectin receptor on thymocytes and the fibro- 
blast receptor. The possibility that these differences could be 
accounted for by carbohydrate differences seems unlikely 
because treatment of receptors from either thymocytes or 
fibroblasts with N-glycanase (Chu,  1986;  Plummer et al., 
1984) resulted in equal reductions in the molecular weights 
of each of these receptors (Cardarelli and Pierschbacher, un- 
published results).  It is conceivable that these size differ- 
ences as well as immunologic differences among fibronectin 
receptors on different cell types detected by others (Hosein 
and Bianco, 1985) could be due to differences in posttransla- 
tional  modifications  or  alternative  mRNA  splicing,  or  it 
could be that distinct fibronectin receptors exist on different 
cell types as is the case with fibroblasts and platelets (Pytela 
et al.,  1986). 
The sensitivity of the lymphocyte fibronectin receptor to 
proteolysis by trypsin also suggests that differences exist in 
the  receptors from the different sources.  Only 7%  of the 
mass of the larger subunit of the lymphocyte receptor and 2 % 
of the lower subunit was removed by treatment with trypsin, 
indicating that the majority of the molecule is quite resistant 
to this enzyme. The fact that the majority of the molecule re- 
mained associated with the cell surface after trypsinization 
indicates that peptide bonds near the amino termini of the 
two polypeptides were cleaved in that the carboxy termini 
appear to be cytoplasmic (Argraves et al.,  1986 and unpub- 
lished).  That  trypsinized  lymphocytes  no  longer  bind  to 
fibronectin suggests that treatment with this enzyme destroys 
the binding  site on the receptor.  However, it  is  not clear 
whether the actual binding site is removed or whether the 
functional conformation of the receptor is destroyed by this 
procedure. 
Burns et al. (1986) have presented evidence that the inter- 
action of several types of leukocytes with fibronectin is de- 
pendent on a surface molecule which shares an immunologic 
determinant with the platelet protein llb/IIIa. Our results in- 
dicate that the fibronectin receptor expressed by thymocytes 
is similar to that of fibroblasts but differs in some respects. 
Therefore,  because  the  extent  of the  family  of adhesion 
receptors is not yet known and because minor differences in 
the receptors from the different cell types do exist, one must 
exercise caution in drawing conclusions about the absolute 
identity  of  functionally  similar  receptors  from  different 
sources until their complete structure is known. 
Taken together, the data presented here establish the exis- 
tence of adhesion receptors on both thymocytes and T lym- 
phoma cells that recognize fibronectin via its RGD sequence. 
These receptors differ from those found on fibroblasts yet 
they are  similar  in  many  respects.  The presence of these 
receptors  on  thymocytes indicates  that  the  interaction  of 
thymocytes with the extracellular matrix may be important 
in their differentiation or migration during development. An- 
tibodies to these murine receptors are currently being pro- 
duced so that their precise localization in lymphoid tissues 
can be determined. 
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